A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders |
| |
Authors: | G M Newburn A R Fraser D B Menkes P E Mullen |
| |
Affiliation: | Department of Psychiatry, Rotorua Hospital. |
| |
Abstract: | The antidepressant efficacy and side-effect profile of amitriptyline were compared to those of moclobemide, a reversible monoamine oxidase inhibitor with selectivity for the type A isozyme. Forty nine patients with DSM-III major depression were randomly assigned to receive either amitriptyline or moclobemide. Thirty seven patients (amitriptyline n = 16, moclobemide n = 21) completed the six week protocol, which was conducted under double blind conditions. The results indicated a comparable antidepressant time course and efficacy for the two treatments. Amitriptyline produced significantly more sedation and antimuscarinic side-effects. Moclobemide appears to be a well tolerated antidepressant without the liability to produce significant postural hypotension and without the need for a tyramine-poor diet. |
| |
Keywords: | |
|
|